Despite limited growth and weaker momentum, LanZhou Foci Pha...
Despite limited growth and weaker momentum, LanZhou Foci PharmaceuticalLtd's high P/E ratio indicates investors' hope for a business turnaround. However, if P/E aligns with recent growth rates, shareholders may face disappointment. Weak earnings and slower growth could risk investments and potential investors may pay an excessive premium.
LanZhou Foci Pharmaceutical Co.,Ltd.'s (SZSE:002644) 28% Share Price Plunge Could Signal Some Risk
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment